“…Further, various novel phosphorylated penta-1,4-dien-3-one derivatives (e.g., 3h , EC 50 104.2 μg/mL, and 3j , EC 50 290.0 μg/mL) and dithioacetal derivatives (e.g., Y21 , EC 50 329.5 ± 1.5 μg/mL) exhibited good antiviral activity against TMV and inhibited TMV activity by binding to TMV CP. − In 2021, Guo et al designed and synthesized novel acylurea derivatives (e.g., 7x , EC 50 211.8 μg/mL) with good antiviral activity, which could target TMV CP and inhibit TMV self-assembly thereby suppressing viral infestation . In 2022, Liao et al synthesized a series of camalexin derivatives, screened them against TMV CP, and found that compound 5a caused fusion and disassembly of 20S CP discs, thus affecting the assembly of viral particles . In the same year, Dai et al synthesized a ferulic acid derivative ( D3 , EC 50 38.1 μg/mL) containing β-amino alcohols.…”